Biogen Inc.
225 Binney Street
Cambridge, Massachusetts 02142
May 24, 2022
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Re: | Biogen Inc. |
Registration Statement on Form S-4
File No. 333-265023
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Biogen Inc. hereby requests acceleration of the effective date of its Registration Statement on Form S-4 (File No. 333-265023) so that it may become effective at 4:00 p.m. Eastern time on May 26, 2022, or as soon thereafter as practicable.
[Remainder of this page intentionally left blank]
| Very truly yours, | ||
| Biogen Inc. | ||
| By: |
/s/ Michael Dambach | |
| Name: |
Michael Dambach | |
| Title: |
Vice President and Treasurer |